Jaguar Health (JAGX) announced that a prominent equine facility has placed the first order for the company's first-generation of Equilevia, a non-prescription, personalized, premium product for total gut health in high-performance equine athletes. The company announced that Equilevia's ingredients are isolated and purified from the medicinal Croton lechleri tree, which is sustainably harvested from the rainforest. The product acts locally in the gut with minimal systemic absorption, with no effect on gastric pH. Moreover, horse racing authorities do not ban the use of Equilevia and therefore it does not require withdrawal prior to racing.